Johnson & Johnson - Company Profile
Powered by 
All the sales intelligence you need on Johnson & Johnson in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Johnson & Johnson fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Johnson & Johnson.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreJohnson & Johnson (J&J) is a healthcare company engaged in the research, development, manufacture, and sale of innovative medicines and medical technologies. The company conducts business through its operating companies. It provides pharmaceutical products for therapy areas related to immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopedic, neurovascular care, general surgery, and vision care fields. The company offers its products to retailers, wholesalers, healthcare professionals, and hospitals. It operates manufacturing units in the US, Europe, Asia-Pacific, Africa, Western Hemisphere (excluding the US), and Latin America. J&J is headquartered in New Brunswick, New Jersey, the US.
Headquarters
United States of America
Address
One Johnson & Johnson Plaza, New Brunswick, New Jersey, 08933
Website
www.jnj.com
Telephone
1 732 5240400
No of Employees
138,200
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
JNJ (NYSE)
Revenue (2024)
$94.2B
6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
90.6%
(2024 vs 2023)
Market Cap*
$611.4B
Net Profit Margin (2024)
XYZ
79.7%
(2024 vs 2023)
* As of and is in US$
Johnson & Johnson premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pharmaceutical | Johnson’s |
| Immunology: | Benadryl |
| Rheumatoid Arthritis | Listerine |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In June, the company entered into an agreement to acquire Firefly Bio, Inc., a company advancing its proprietary Firelink degrader antibody conjugate platform, for US$1 billion. |
| 2026 | New Products/Services | In May, the company introduced the interactive Gut Tunnel experience in Singapore. |
| 2026 | Contracts/Agreements | In April, the company signed a nationwide, multi-channel strategic partnership with Shanghai Pharmaceuticals Holdings for injectable drugs in the field of mental health and neurological disorders. |
Competitor Comparison
| Key Parameters | Johnson & Johnson | Eli Lilly and Co | Pfizer Inc | Novartis AG | Sanofi |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Switzerland | France |
| City | New Brunswick | Indianapolis | New York City | Basel | Paris |
| State/Province | New Jersey | Indiana | New York | Basel-Stadt | Ile-de-France |
| No. of Employees | 138,200 | 50,605 | 75,000 | 75,267 | 76,493 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Joaquin Duato | Chairman; Chief Executive Officer | Executive Board | 2023 | 63 |
| Joseph J. Wolk | Executive Vice President; Chief Financial Officer | Senior Management | 2018 | 59 |
| James Swanson | Chief Information Officer; Executive Vice President | Senior Management | 2022 | 60 |
| Elizabeth Forminard | Chief Legal Officer; Executive Vice President | Senior Management | 2022 | 55 |
| Kristen Mulholland | Chief Human Resources Officer; Executive Vice President | Senior Management | 2024 | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer